Your browser doesn't support javascript.
loading
Effects of GLP-1 and GIP on Islet Function in Glucose-Intolerant, Pancreatic-Insufficient Cystic Fibrosis.
Nyirjesy, Sarah C; Peleckis, Amy J; Eiel, Jack N; Gallagher, Kathryn; Doliba, Andriana; Tami, Abigail; Flatt, Anneliese J; De Leon, Diva D; Hadjiliadis, Denis; Sheikh, Saba; Stefanovski, Darko; Gallop, Robert; D'Alessio, David A; Rubenstein, Ronald C; Kelly, Andrea; Rickels, Michael R.
Afiliação
  • Nyirjesy SC; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Peleckis AJ; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Eiel JN; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Gallagher K; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Doliba A; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Tami A; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Flatt AJ; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • De Leon DD; Division of Endocrinology and Diabetes, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Hadjiliadis D; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA.
  • Sheikh S; Division of Pulmonary Medicine, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Stefanovski D; New Bolton Center, University of Pennsylvania School of Veterinary Medicine, Kennett Square, PA.
  • Gallop R; Department of Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • D'Alessio DA; Department of Mathematics, West Chester University of Pennsylvania, West Chester, PA.
  • Rubenstein RC; Division of Endocrinology and Metabolism, Department of Medicine, Duke University School of Medicine, Durham, NC.
  • Kelly A; Division of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
  • Rickels MR; Division of Endocrinology and Diabetes, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
Diabetes ; 71(10): 2153-2165, 2022 10 01.
Article em En | MEDLINE | ID: mdl-35796669

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Cística / Peptídeo 1 Semelhante ao Glucagon Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Diabetes Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Cística / Peptídeo 1 Semelhante ao Glucagon Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Diabetes Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos